Blighia sapida (BS) 
INTRODUCTION
Diabetes mellitus (DM) is a metabolic disturbance defined by hyperglycemia caused by lack of insulin or disruption of insulin signaling as a result of lack of hypoglycemic agent or insensitivity of insulin hormone. DM is related to aberrant metabolism of macromolecules [1, 2, 3] . The illness happens as a results of exocrine gland β-cells injury, resulting in decreased secretion of insulin. It might conjointly arise once the receptors are resilient to the roles of insulin [4] . Hyperglycemia reoccurrence during diabetes leads to body proteins being glycated, that successively results in complications affecting body organs and arteries [5] . Stiffening of red blood cells could be liable for and or related to, large vessel disease in diabetes state [6] . Management option for DM is predicated on insulin therapy and oral hypoglycemic agents that have several facet effects [7] . In diabetes state, the effects and locations of involvement in biochemical activity are varied and elevated serum total triglyceride level, increase level of transaminase, creatinine and urea are of concerned [6] . Additional major issue, that confounds diabetic state, leading to death is hyperlipidemia [8] . Different ways to this fashionable pharmacotherapy of diabetes mellitus are desperately required, attributed to the lack of accessible therapies to manage all the pathological basis of the ailment, in addition to the mammoth cost and poor accessibility for several populations in the developing world [6] . Therefore, plants use as medical aid for diabetes is inspired and acclaimed, though, a number of them are lacking scientific examination.
Blighia sapida K.D. Koenig, also known as ' Akee apple' in English, belongs to the plant family called Sapindaceae and it is noted for its highly characteristic reddish fruits. The species in this family include B. sapida K.D. Koenig, B. unijugata Baker, and B. welwitschii (Hiern) Radlk. It is recognized as 'isin' in Yoruba, 'gwanja kusa' in Hausa and 'okpu' in Igbo [9] . B. sapida K.D. Koenig is distributed throughout Nigeria [10] . B. sapida could be a therapeutic herbal plant ordinarily utilized by trado-medical healers in Nigeria, and highly appreciated in West Africa for the management of various diseases like diabetes mellitus [11] . The fruit has inhibitory effect against α-glucosidase and α-amylase as reported by Kazeem et al. [12] . B. sapida root extract has been shown to possess normoglycemic impact [13] . The stem bark has been shown to ameliorate pancreatic β-cell dysfunction in diabetic rats [11] . Therefore, this study was focused on analyzing the effects of Blighia sapida K.D. Koenig stem bark on antihyperlipidemic and hematological parameters in diabetic rats.
METHODS

Plant material
Fresh stem bark peelings of B. sapida Koenig was obtained at a farm in the suburbs of Abeokuta, Ogun State, Nigeria. The plant was identified and authenticated by a senior taxonomist at the university herbarium with herbarium approval number (UHAE/2016/020). All plant names in this manuscript are formatted according to the latest revision in "The Plant List" (www.theplantlist.org).
Plant extracts preparation
Stem bark was air-dried in the laboratory at temperature (25 ± 2°C), pulverized using an electrical blender and the powders obtained stored till further use. The small grained sample (100 g) was extracted with solvent combination of 70% ethanol for 48 h. The extract was filtered and thereafter evaporated to dryness using rotary evaporator [14] . The concentrated extract was stored at 4 °C until further analysis. The extraction yield is as follows.
Weight of the extract Percentage yield = -----------------x 100 % [15] Weight of powdered stem bark
The percentage yield of the extraction was 19.1 %.
Experimental Animals
Six-week-old male Wistar rats with an initial mean body weight of 150 ± 50 g were obtained from Animal house Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria. The animals were divided into six groups of five each and adapted to investigational condition for two weeks. The animals were housed in clean metabolic cages that provided free access to water and rat pellets (Ladokun Feeds, Nigeria). The principles of Animal Care (Public Health Services, 1986) was monitored through the duration (for twenty-one days) of the experiment. The standards of National Institute of Health (NIH publication 1985) for experimental maintenance and handling of animals was conformed to [16] . The ethical committee of the Afe Babalola University approved this study with approval number (ABUAD/ACA/121). The rats in this study followed the rules of the established Animal Ethical Committee of Afe Babalola University.
Animal grouping
The animals were randomly divided into six groups of 5 animals namely;
Normal control group (distilled water), Diabetic untreated group (65 mg/kg Alloxan, intraperitoneal) Diabetic + 5 mg/kg bw Diabetic + 50 mg/kg bw BSE, oral gavage Diabetic + 100 mg/kg bw BSE, oral gavage Diabetic + 150 mg/kg bw BSE, oral gavage Dose dependent study was previously carried out in our laboratory with three different doses of BSE (50, 100 and 150 mg/kg body weight) based on ethnobotanical survey conducted by [11] .
Induction of diabetes
In induction of diabetes, alloxan (65 mg/kg body weight) was dissolved in sterile physiological saline and intraperitoneal injected (5.6 mL) into the animals in the diabetic control, diabetic + glibenclamide (5 mg/kg body weight), diabetic + 50 mg/kg body weight of BSE (2.5 mL), diabetic + 100 mg/kg body weight of BSE (5.5 mL), diabetic + 150 mg/kg body weight of BSE (8.5 mL) groups to induce β-cell dysfunction. This was done in morning after the rats have been fasted overnight, while the animals in normal control group received a similar volume of distilled water. Fortyeight hours after induction, fasting blood glucose (FBG) of all rats were measured by collecting blood from the tail vein using a portable glucometer. Animals with a FBG level ≥ 200 mg/dl were considered as diabetic while animals with a FBG level < 200 mg/dl were disqualified [17] .
Collection of blood
Under di ethyl anaesthesia, the neck area of the rats was quickly cleared to expose the jugular veins. Blood samples from each animal was collected after 21 days through their jugular vein and preserved until further processing. The blood sample was collected into a dry tube and allowed to clot for 30 min before centrifuging at 3500 rpm for 10 min to collect the serum for further study [18] .
Biochemical parameters
Serum lipid concentrations, in additional to aspartate and alanine aminotransferases and alkaline phosphatase as well as urea and creatinine concentrations were assayed using commercially available kits (DRG Diagnostics, USA) according to manufacturer's protocol.
Low density lipoprotein-cholesterol was estimated according to equation as shown below:
LDL-cholesterol (mg/dl) = TC-HDL-(TG/5) Non-HDL-cholesterol (mg/dl) = TC -HDL-cholesterol Whereas, TG/5 is equivalent to the concentration of very low density lipoprotein. VLDL means very low density lipoprotein, TG means triacylglycerol Atherogenic index (AI) was calculated and expressed as:
Coronary artery risk index (CRI) was deduced using the formula below.
Whereas, HDL means high density lipoprotein-cholesterol, TC means total cholesterol
Hematological analysis
The hematological parameters like packed cell volume (PCV), hemoglobin (Hb), WBC count and WBC percentage composition, mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC) and mean corpuscular volume (MCV) were analysed by means of an automated analyzer (Sysmex K-2 IN, Japan). Total white blood cell counts (WBC) was analysed by the hemocytometer method, whereas smears were ready and marked by using Leishman technique and numbered by the longitudinal counting method to resolve differential count. Packed cell volume (PCV) was analyzed by the micro-haematocrit method while hemoglobin (Hb) levels was assessed by the cyano methemoglobin method [19] .
Data analysis
Data are presented as the mean ± SD (n=5). The data were analyzed by one-way analysis of variance via a statistical software package (SPSS, Version 20.0, IBM Corporation, NY, USA) one-way ANOVA using Duncan multiple range post-hoc test (DMRT). Values were considered to be significantly different at p < 0.05.
RESULTS
The effect of Blighia sapida stem bark ethanol extract on fasting blood glucose level of alloxan-induced diabetic rats is presented in Table 1 . Fasting blood glucose levels in all animals induced with alloxan was significantly increased, compared to the normal control group, p < 0.05. The fasting blood glucose levels were however, reduced considerably in diabetic + 50 mg/kg body weight of BSE, diabetic + 100 mg/kg body weight of BSE and diabetic + 150 mg/kg body weight of BSE groups in addition to glibenclamide treated animals. Data are presented as the mean ± SEM of 5 animals. Values with diff erent superscript letters (a-e) along a column for a given parameter are signifi cantly diff erent from each other between groups at P < 0.05.
Serum lipid concentrations, calculated atherogenic index (AI) and coronary risk index (CRI) scores are displayed in Table 2 . High serum concentrations of TC, TG, LDLcholesterol and non-HDL-cholesterol levels in addition to analyzed AI and CRI scores with progressive decrease in serum HDL-cholesterol were observed within diabetic untreated group compared to the normal control. Administration with B. sapida stem bark ethanol extract to diabetic animals considerably and dose-dependently abridged TC, TG and LDL-cholesterol levels, AI and CRI in 50 ,100 and 150 mg/kg bw of BSE and glibenclamide groups compared with the diabetic untreated. Although considerably increase in serum HDL-cholesterol level was observed in the B. sapida K.D. Koenig stem bark ethanol extract treated groups compared to the diabetic untreated.
Serum ALT, AST, ALP, urea and creatinine levels are presented in Table 3 . Concentrations of serum ALT, AST, ALP, urea and creatinine levels were considerably increased within the diabetic untreated compared to the normal control. On the other hand, administration of B. sapida stem bark ethanol extract to diabetic animals progressively ameliorated these changes in 50, 100 and 150 mg/kg bw of BSE and glibenclamide treated groups.
Hemoglobin (Hb) levels, packed cell volume (PCV) count, red blood cells (RBCs), white blood cells (WBCs), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), neutrophils (N), lymphocyte (L), monocytes (M) and eosinophils (E) are displayed in Table 4 . Hemoglobin (Hb) levels, packed cell volume (PCV), red blood cells (RBCs) levels, white blood cells (WBCs), mean corpuscular haemoglobin concentration (MCHC), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), neutrophils (N), lymphocyte (L), monocytes (M) and eosinophils (E) were evidently reduced in diabetic untreated compared to normal control. Though, administration of 50-150 mg/kg bw of BSE groups demonstrated a considerably increase on the biochemical parameters mentioned above. Glibenclamide treatment conjointly considerably increase these biochemical parameters.
DISCUSSION
In this study, we examined the effect of oral administration of B. sapida Koenig stem bark ethanol extract in diabetic rats through twenty-one days' post-treatment period. The typical characteristics of diabetic dyslipidemia include high serum cholesterol, triglyceride (hypertriglycerolemia), LDL-cholesterol concentrations and low HDL- cholesterol (hypercholesterolemia) contents [20] . Likewise, the increase levels of LDL-C and atherogenic index by the alloxan indicates predisposition to cardiovascular risk [21] . The significant elevation in cholesterol, triacylglycerol and LDL-cholesterol concentrations in the diabetic rats treated with distilled water may be owing to improved mobilization of free fatty acids from the peripheral fat depots. This obvious hyperlipidemia that describe the diabetic state may hence be considered as a consequence of uninhibited actions of lipolytic hormones on the fat depots [22] . Aberrant lipid metabolism, resulting in amassing of LDL-C, VLDL and total cholesterol in addition to reduced HDL-cholesterol, is often related to diabetes mellitus [23] . Elevated levels of LDL, VLDL, atherogenic index, coronary artery index and total cholesterol are thought of as main menace for cardiovascular disease (CVD). On the contrary, elevated HDL-cholesterol that functions in the transport of cholesterol from the periphery to the liver reduces the chance of CVD [24] . Oral intervention of B. sapida stem bark ethanol extract and the standard drug both averts dyslipidemia, decreases the chance of developing atherogenesis and coronary artery disease and amplified serum HDL-cholesterol level. This is in accordance with newly published studies [8, 25, 26, 27] .
Aminotransaminses are significant and key enzymes involved in the breakdown of amino acids into α-keto acid, which are directed for complete metabolism via the Krebs cycle and electron transport chain. They are considered exact biomarkers for liver damage [28] . In hepatocyte injury, there is impairment in the biomembrane of liver cells which leads to permeability of cytoplasmic enzymes such as AST and ALT which leak into the circulatory system and result in significant elevation in their activities in serum. Moreover, modification of membrane bound alkaline phosphatase (ALP) affects membrane permeability and produces imbalance in the transport of metabolites [29] . Elevated serum transaminase, alanine aminotransferase (ALT), aspartate aminotransaminse (AST), alkaline phosphatase (ALP), urea and creatinine levels are thought of as biomarkers of hepato-renal damage, related to liver disease and hyperglycaemia [30, 31] . Treatment with B. sapida stem bark ethanol extract at 50 -150 mg/kg bw significantly reduced (p < 0.05) ALT, AST, ALP, urea and creatinine levels, indicating that B. sapida bark might ameliorates alloxan-induced injury in diabetic rats. The considerably lower serum creatinine and urea levels in the B. sapida stem bark ethanol extract treated groups compared with diabetic untreated, indicates its doable impact on the betterment of diabetes induced kidney injury [32, 33] .
Vital reductions in haemoglobin (Hb) levels, packed cell volume (PCV), red blood cells (RBCs), white blood cells (WBCs), mean corpuscular haemoglobin concentration (MCHC), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), neutrophils (N), lymphocyte (L), monocytes (M) and eosinophils (E) were observed (p < 0.05) in the diabetic untreated rats. Substantial significant (p < 0.05) increase in haematological parameters occurred upon administration of the B. sapida stem bark ethanol extracts at 50 -150 mg/kg doses compared to the diabetic untreated rats. Constant trend was observed in the levels of parameters mention above for glibenclamide treated rats. Though these effect were more pronounced in the 150 mg/kg bw of BSE group [6, 34] . This may be as a result of the presence of metabolites like saponins, phenols and alkaloids [35 36, 37] . Blood examination could be a great means of evaluating the well-being standing of animals because it performs significant physiological and biological roles in organisms [38] . However, in diabetic state, the extra glucose present reacts with haemoglobin to produce glycated haemoglobin. This therefore shown that diabetic untreated rats displayed aberrations in the hematological profiles. A number of these aberrations may result in destruction of developed red blood cells resulting in the small Hb counts accompanied with the drop in the RBC and PCV [39, 40] . Extremely low values of RBC, Hb and hematocrit might specify anemia [34, 39] . Furthermore, modulatory effect and confined toxicity might ensue as noted within the lymphocytes and neutrophils of the diabetic untreated animals. Administration of the B. sapida stem bark ethanol extract stimulates positive changes in the hematological profile of the diabetic rats. Hence, upsurge in RBC by the extract is a sign of its restorative impact on alloxan-induced anemia whereas the alteration in level of lymphocytes by the extract could specify an anti-infection activity [36, 40, 41] .
CONCLUSION
The results from this study indicates that B. sapida ethanol stem bark extract possesses robust anti-diabetic activity via improving dyslipidemia and ameliorate anemic condition in diabetic rats. Hence, ethanol extract of B. sapida K.D. Koenig stem bark could be a possible antidiabetic natural product with no significant side effects. Further studies to isolate the bioactive principles using HPLC, complete safety assessment as well as activities on metabolizing enzymes and pro-inflammatory biomarkers should be carried out in vivo.
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